| Date | Title | | | 05/08/13 | Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference| PARSIPPANY, N.J.--(BUSINESS WIRE)--May. 8, 2013--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that
James Scibetta, chief financial officer of Pacira Pharmaceuticals, is
scheduled to present at the Bank of America Merrill Lynch 2013 Health
Care Conference on Wednesday, May 15, 2013, at 5:00 p.m. PT at the
Encore at the Wynn in Las Vegas. Mr. Scibetta is expected to present an
overview of the company.
A live audio webc... |
|  | | 05/08/13 | Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results| Company Will Host Conference Call Today at 9 a.m. ET
PARSIPPANY, N.J.--(BUSINESS WIRE)--May. 8, 2013--
Pacira
Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced consolidated
financial results for the quarter ended March 31, 2013 and provided
updates on the commercial launch of EXPAREL®
(bupivacaine liposome injectable suspension) for postsurgical pain in
the United States.
“We saw a solid quarter in what was the fourth quarter ... |
| | | 05/06/13 | Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control| Data Presented at Annual Meetings of Leading Regional Anesthesia
Societies Demonstrate Analgesia for Up to 72 Hours and High Patient
Satisfaction
PARSIPPANY, N.J.--(BUSINESS WIRE)--May. 6, 2013--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced findings from
two new studies supporting the use of EXPAREL® (bupivacaine
liposome injectable suspension) infiltrated into the transversus
abdominis plane for postsurgical pain managem... |
| | | 05/01/13 | Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call| PARSIPPANY, N.J.--(BUSINESS WIRE)--May. 1, 2013--
Pacira
Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that financial
results for the company’s first quarter ended March 31, 2013, will be
released before the market opens on Wednesday, May 8, 2013. The Pacira
management team will host a conference call to discuss the company’s
financial results and recent and upcoming developments on Wednesday, May
8, 2013, at 9 a.m. ET. The call can be acces... |
| |
|
